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Aims Myocardial blood ﬂow (MBF) is the gold standard to assess myocardial blood supply and, as recently
shown, can be obtained by myocardial contrast echocardiography (MCE). The aims of this human study
are (i) to test whether measurements of collateral-derived MBF by MCE are feasible during elective
angioplasty and (ii) to validate the concept of pressure-derived collateral-ﬂow assessment.
Methods and results Thirty patients with stable coronary artery disease underwent MCE of the
collateral-receiving territory during and after angioplasty of 37 stenoses. MCE perfusion analysis was
successful in 32 cases. MBF during and after angioplasty varied between 0.060–0.876 mL min21 g21
(0.304+ 0.196 mL min21 g21) and 0.676–1.773 mL min21 g21 (1.207+ 0.327 mL min21 g21), respect-
ively. Collateral-perfusion index (CPI) is deﬁned as the rate of MBF during and after angioplasty
varied between 0.05 and 0.67 (0.26+ 0.15). During angioplasty, simultaneous measurements of mean
aortic pressure, coronary wedge pressure, and central venous pressure determined the pressure-
derived collateral-ﬂow index (CFIp), which varied between 0.04 and 0.61 (0.23+ 0.14). Linear-
regression analysis demonstrated an excellent agreement between CFIp and CPI (y ¼ 0.88xþ 0.01;
r2 ¼ 0.92; P, 0.0001).
Conclusion Collateral-derived MBF measurements by MCE during angioplasty are feasible and proved
that the pressure-derived CFI exactly reﬂects collateral relative to normal myocardial perfusion in
humans.
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Introduction
The coronary collateral circulation constitutes an alterna-
tive blood supply to myocardium jeopardized by ischaemia,
and its protective role has been demonstrated by numerous
investigations.1 Of considerable clinical relevance, coronary
collateral arteries have become a target for novel treatment
strategies by therapeutic arteriogenesis in patients
with severe coronary artery disease (CAD).2–4 In order to
demonstrate the efﬁcacy of pro-arteriogenic substances, it
is indispensable to quantitatively assess collateral ﬂow,
which in turn entails selective delineation of collateral path-
ways. The ﬁrst technique fulﬁlling these requirements used
coronary pressure measurements distal to a stenosis during
angioplasty, i.e. coronary wedge pressure, which was
related to angiographically visible collaterals.5 The current
reference method measures collateral ﬂow as a fraction of
normal ﬂow using a collateral-ﬂow index (CFI), which is
derived from simultaneous measurements of mean aortic
pressure, coronary wedge pressure, and central venous
pressure (CVP) during angioplasty. This CFI is theoretically
well deﬁned6 and has been conﬁrmed by several invasive
studies.7–9 Moreover, Matsuo et al.10 validated the index
against perfusion defects, using 99 mTc-sestamibi during
angioplasty. However, the direct veriﬁcation of the CFI vs.
the gold standard of myocardial blood supply assessment,
that is, myocardial blood ﬂow (MBF) (mL min21 g21), is
still lacking. MBF, deﬁned as blood ﬂow (mL min21) into a
region relative to its mass (g), can be obtained by positron
emission tomography and lately by myocardial contrast
echocardiography (MCE).11
The objectives of this human study are (i) to demonstrate
that collateral-derived MBF can be obtained by MCE during
elective angioplasty and (ii) to validate the concept of
pressure-derived collateral-ﬂow assessment by simultaneous
measurements of coronary pressure and MBF.
Methods
Angioplasty model
Figure 1 depicts the ﬂow model consisting of a myocardial area that
is supplied by a stenotic coronary artery and an alternative pathway
representing coronary collaterals. The biophysical properties of the
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myocardium are characterized by its ﬂow resistance (Rmyo,
mmHg min mL21) and mass (mmyo, g). The collateral-perfusion
index (CPI, 1) is deﬁned as collateral-derived MBF (MBFc,
mL min21 g21) during balloon occlusion (left-hand panel) relative
to normal MBF (MBFn, mL min
21 g21) after removal of the stenosis
(right-hand panel):
CPI ¼ MBF c
MBF n
¼ Q c=m myo
Q nm myo
¼ Q c
Q n
: ð1Þ
Collateral-derived ﬂow (Qc, ml min
21) and normal coronary ﬂow
(Qn, ml min
21) are controlled by their perfusion pressure, i.e. cor-
onary wedge pressure (Poccl, mmHg) during angioplasty and aortic
pressure (Pao, mmHg) after successful angioplasty, and the CVP
(mmHg), which acts as backpressure:
Q c ¼ P occl  CVPR myo ð2Þ
and
Q n ¼ P ao  CVPR myo : ð3Þ
The pressure-derived CFI (CFIp, 1) equals:
CFI p ¼ P occl  CVPP ao  CVP ¼
Q c
Q n
¼ CPI: ð4Þ
Study population and protocol
For this pilot study, we planned to investigate 30 patients with
stable CAD eligible for percutaneous coronary intervention (PCI)
of 1 stenotic lesion. Forty-four consecutive patients (18 years)
referred for elective coronary angiography were initially evaluated
to participate in the study. Six patients refused consent and eight
patients were excluded after the angiographic assessment. The
patients were not screened for echocardiographic image quality
and maintained their routine medication.
All measurements were performed in the catheterization labora-
tory during one session with the patient in supine position lying on
his back. After diagnostic coronary angiography, constant venous
ultrasound contrast agent (UCA) infusion was started and the myo-
cardial territory of the coronary artery undergoing angioplasty,
i.e. the collateral-receiving artery, was imaged by transthoracic
MCE. PCI was performed after stable myocardial enhancement
was reached. During balloon occlusion, myocardial perfusion
sequences were captured while continuously recording coronary
wedge pressure, aortic pressure, and CVP. After successful com-
pletion of the intervention, that is, restoration of normal blood
ﬂow at rest, perfusion imaging of the same territory was repeated
following cessation of reactive hyperaemia. MCE und pressure
studies were performed and analysed by two independent
examiners blinded to the other methods’ results. The study protocol
was approved by the Ethics Committee of the University of Bern,
and all participants gave written informed consent to participate
in the study.
Cardiac catheterization and pressure
measurements
After two puffs of isosorbide dinitrate, diagnostic coronary angio-
graphy was performed via the right femoral artery approach,
using ﬁve French Judkins catheters. Indication for ad hoc PCI is
based on the visual estimate of the stenosis per cent diameter
reduction. For PCI and coronary pressure measurements, a six
French-guiding catheter and a 0.014 in. guidewire equipped with a
pressure sensor at the tip (PressureWire, RADI Medical, Uppsala,
Sweden) was used. Simultaneous measurements of mean aortic
pressure through the angioplasty-guiding catheter, coronary wedge
pressure distal to the stenosis undergoing PCI, and CVP via a
femoral venous access were performed during balloon occlusion.
Stenosis severity was quantitatively assessed ofﬂine as per cent
diameter reduction of the vessel (Philips DA, Best, The
Netherlands).
Myocardial contrast echocardiography
Ultrasound contrast agent
UCA was administered via the right cubital vein, using parallel infu-
sion of FS069 (OPTISON, Amersham Health SA, Oslo, Norway) 3 mL
at a rate of 10–30 mL h21 (Perfusor fm, B. Braun Melsungen AG,
Melsungen, Germany) and physiological saline at a rate of
400 mL h21 (VOLUMEDw aVP2001, arcomed ag, Regensdorf,
Switzerland). The UCA infusion pump was manually agitated to
guarantee UCA homogenization.
Data acquisition
Transthoracic imaging was performed with an Acuson Sequoia C256
ultrasound scanner (Siemens Medical Solutions, Mountain View, CA,
USA) equipped with a 3V2c transducer and Coherent Contrast Ima-
gingw. Settings were as follows: MI for microsphere detection
0.08, MI for microsphere destruction 1.3, dynamic range 60 dB,
and linear post-processing. The image plane was adjusted to the
myocardial territory of the coronary artery to be dilated, i.e. the
collateral-receiving territory. Gain was adjusted for optimal visual-
ization of the myocardium and held constant throughout the image
acquisition. Destruction-reﬁll sequences were generated using the
manual bubble destruction (MBD) feature of the scanner and
recorded digitally for ofﬂine image analysis. The clip length was
set to 200 frames with a triggered interval of 75 ms, resulting an
acquisition time of 15 s. Prior to MBD, two cardiac cycles were
captured for the calculation of the relative blood volume.
Data analysis
Image visualization and quantiﬁcation was done with DataPro 2.11
(Noesis S.A., Courtaboeuf, France). Logarithmic signal compression
was removed, and linearized signal intensity data were expressed
in arbitrary units. Quantitative perfusion analysis was performed
on end-systolic frames selected from the perfusion sequence.
Appropriate regions of interest were placed and tracked manually
within the myocardium and an adjacent region within the left ven-
tricular cavity.11 Myocardial intensity data were corrected for non-
contrast signals arising from the tissue by subtracting the signal
intensity of the ﬁrst frame after MBD. Myocardial plateau intensity
A was calculated by averaging myocardial signal intensity data
from frames before MBD (Figure 2). Parameter b (min21) was
derived from the ﬁtting of myocardial intensity data after MBD to
the reﬁll equation [Eq. (5)].
yðtÞ ¼ A  ð1 eb  tÞ: ð5Þ
Figure 1 Schematic model representing the coronary circulation during (left
panel) and after successful angioplasty (right panel). The guidewire is
equipped with a pressure sensor at its tip distal to the stenosis.
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Figure 2 Perfusion sequence and analysis of the interventricular septum recorded from the apical four-chamber view during (A) and after angioplasty (B). The
numbers 1–4 within the reﬁll curves indicate frame numbers from left to right. Left ventricular (P) and myocardial (†) signal intensities of the mid-segment are
plotted against time. Upper and lower dotted lines indicate mean left ventricular signal intensity ALV and myocardial plateau signal intensity A, respectively.
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Averaging left ventricular signal intensity data of all but the
frames during and the ﬁrst one after MBD yielded ALV and the rela-
tive blood volume (rBV, mL mL21):
rBV ¼ A
A LV
: ð6Þ
MBF was calculated according to Eq. (7) with a tissue density rT
of 1.05 g mL21:
MBF ¼ rBV  b
r T
: ð7Þ
Statistical methods
Demographic and clinical data were expressed as mean+ SD.
Paired, two-sided t-tests were used for the comparison of pressure
and perfusion data. Correlations were performed using linear-
regression analysis, and the accuracy of the prediction was
measured by the standard error of the estimate. Statistical signiﬁ-
cance was deﬁned at a probability value P , 0.05. The Bonferroni
correction was used for multiple comparisons between CPI and the
pressure indices Poccl/Pao and CFIp. Agreement between two
measurement techniques was established using Bland–Altman
analysis by plotting the differences between the two techniques
against the mean values of the two techniques; values of
mean+ 2SD of measurement differences were added to the plots.
The range within which the measurement differences were required
to lie was not pre-deﬁned.
Results
The past medical history of the 30 patients revealed stable
angina in 25 cases. Table 1 summarizes patient’s character-
istics and angiographic data. Left ventricular ejection frac-
tion and end-diastolic pressure (LVEDP) ranged between 30
and 70% and 3 and 1 mmHg, respectively. PCI was performed
in 37 stenotic coronary arteries. The per cent diameter
reduction ranged between 30 and 100%, including seven
non-signiﬁcant stenoses. Angioplasty of non-signiﬁcant ste-
noses was performed because of visual overestimation in
six cases (41–49% diameter reduction by quantitative analy-
sis) and because of an ulcerated plaque in one case (30%
diameter reduction). During angioplasty of 37 stenoses,
angina was present in 19 and ST-segment changes on the
surface ECG in 20 cases. Invasive pressure measurements
were obtained from all lesions (Table 2). MCE perfusion
analysis during and after angioplasty was completed in 32
territories (Table 2) and failed in one lateral and four
inferior territories. The causes for unsuccessful data acqui-
sition of the four inferior territories were premature study
termination due to an intervention-related serious adverse
event in one patient, technical problems in two cases
(scanner dysfunction and lack of synchronicity between
sonographer and interventionalist), and poor image quality
in one patient with severe chronic obstructive pulmonary
disease.
Figure 2 summarizes perfusion sequences and analyses
during and after PCI of a left anterior descending coronary
artery stenosis with a 52% diameter reduction and a
pressure-derived CFI of 0.17. Visual comparison of the per-
fusion sequences suggests modest collateralization indicated
by decelerated UCA reﬁll during balloon inﬂation. MBF during
and after successful angioplasty was 0.161 mL min21g21 and
0.823 mL min21 g21, respectively, resulting in a CPI of 0.20.
Although relative myocardial blood volumes during and
after PCI were similar (0.088 mL mL21 vs. 0.080 mL mL21),
the corresponding blood volume exchange frequency b
increased from 1.920 to 10.740 min21.
The graphical and statistical analyses of absolute (Poccl,
Poccl-CVP) and relative (Poccl/Pao, CFIp) pressure data vs.
absolute (MBFc) and relative (CPI) perfusion data are
shown in Figures 3 and 4, respectively. Coronary wedge
pressure, effective coronary perfusion pressure (Poccl-CVP),
coronary wedge pressure relative to aortic pressure (Poccl/
Pao) as well as CFI, CFIp, correlated linearly with absolute
collateral-derived myocardial perfusion, and collateral-
derived relative to normal myocardial perfusion. In accord-
ance with the theoretical concept, the best agreement was
found between pressure-derived CFI and CPI.
The measurement differences between non-dimensional
collateral-pressure and -perfusion indexes, i.e. Poccl/Pao,
CFIp, and CPI, are depicted in Figure 5. Averaged over the
entire range, the CPI was overestimated by Poccl/Pao
(0.030+ 0.053, P ¼ 0.003) and underestimated by CFIp
(0.023+ 0.045, P ¼ 0.007). Bland–Altman plots suggest
proportional errors between Poccl/Pao and CPI (Figure 5A)
as well as, but less apparently, between CFIp and CPI
(Figure 5B).
Table 1 Patient characteristics
Patients (women) 30 (5)a
Age (years) 64+ 13
Body mass index (kg m22) 29+ 4
Heart rate (min21) 72+ 13
Mean blood pressure (mmHg) 96+ 11
Left ventricular ejection fraction (%) 60+ 11
Stenosis severity (per cent diameter stenosis) 72+ 21
Distribution of stenoses
,50% 7b
50 to ,70% 10b
70 to ,90% 9b
90 11b
1/2/3 vessel disease, respectively 7/14/9a
PCI of stenosis
Left anterior descending coronary artery 15b
Left circumﬂex coronary artery 12b
Right coronary artery 10b
Values are mean+ SD or number.
aNumber indicates patients.
bNumber indicates stenoses.
Table 2 Pressure and perfusion data
n Mean+ SD Range
Pao (mmHg) 37 94.4+ 12.4 64.0–117.5
Poccl (mmHg) 37 26.7+ 11.7 9.0–57.3
CVP (mmHg) 37 6.6+ 3.0 1.0–13.1
LVEDP (mmHg) 37 11+ 7 3.0–31.0
Poccl2 CVP (mmHg) 37 20.1+ 12.6 3.2–53.3
Poccl/Pao (1) 37 0.29+ 0.13 0.09–0.62
CFIp (1) 37 0.23+ 0.14 0.04–0.61
MBFc (mL min
21 g21) 33 0.304+ 0.196 0.060–0.876
MBFn (mL min
21 g21) 32 1.207+ 0.327 0.676–1.773
CPI (1) 32 0.26+ 0.15 0.05–0.67
n, number of successfully assessed stenosis or territories.
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In our study population, the measurement difference
(CPI2 CFIp) decreased linearly with increasing LVEDP
(Figure 6); CFIp underestimated CPI for ﬁlling pressures up
to 16 mmHg and overestimated CPI for higher ﬁlling
pressures.
Discussion
To date, coronary collateral ﬂow has been assessed by
several qualitative and quantitative methods and has been
compared with clinical markers of collateralization and
prognostic outcome in patients with CAD.1 This study, for
the ﬁrst time, demonstrates that collateral-derived MBF
can be measured using MCE during angioplasty and, in
comparison with simultaneous coronary pressure measure-
ments, conﬁrms the theoretical concept of pressure-
derived collateral-ﬂow assessment in humans. In this
context and for future practical application, the question
arises what would be the ideal parameter to characterize
the coronary collateral circulation and whether it should
be assessed in absolute terms or relative to the ﬂow in the
normally patent coronary artery.
MCE and the assessment of the collateral
circulation
MCE has been proposed for the assessment of collateral-
derived myocardial perfusion by several authors.12–16
Figure 3 Linear-regression analysis of pressure-derived collateral data (Poccl, Poccl2 CVP, Poccl/Pao, and CFIp) vs. absolute collateral-derived myocardial
perfusion (MBFc).
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Two human studies fulﬁlling the mandatory requirements,
i.e. documented total coronary occlusion to avoid concomi-
tant contrast ﬂow via the native vessel, compared MCE and
invasive collateral assessment. In patients with recent
acute myocardial infarction,13 angiographically visible
collaterals correlated poorly with the size of the collatera-
lized area as well as normalized UCA transit rates. In
patients with stable CAD undergoing PCI,15 pressure-
derived CFI was modestly associated with peak signal inten-
sity of UCA transit curves but not with UCA transit rates.
The conﬂicting ﬁndings regarding UCA transit rates may
be explained by the normalization performed by Sabia
et al.13 However, the reliability of UCA transit curve
parameters is limited because of their dependency on
contrast agent concentration and mode of bolus appli-
cation. Furthermore, the studies differed by the setting
(acute myocardial infarction vs. stable CAD) and the refer-
ence method (visual13 vs. pressure-derived15 collateral
assessment).
Reﬁll curve parameter b has been shown to represent MBF
in anaesthetized dogs.17 However, the comparison with PET
revealed only modest agreement between segmental MBF
and b-data in conscious humans.11 Likewise, the present
study demonstrated weak correlation between Poccl and
parameter b during angioplasty (r2 ¼ 0.16, P ¼ 0.02, data
not shown) as well as between CFIp and the ratio of
parameter b during and after angioplasty (r2 ¼ 0.18,
P ¼ 0.01, data not shown).
Figure 4 Linear-regression analysis of pressure-derived collateral data (Poccl, Poccl2 CVP, Poccl/Pao, and CFIp) vs. relative collateral-derived myocardial
perfusion (CPI).
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The methods discussed earlier share a common character-
istic, which limits their applicability. The collateral-derived
blood supply was described either by the collateral-
dependent blood content (peak signal video intensity and size
of the collateralized area) or by the exchange rate of this
blood content (UCA transit rate, parameter b). Our method
overcomes this drawback as the collateral-dependent
blood volume and its exchange frequency are combined to
MBF given in mL min21 g21 [Eq. (7)]. With respect to the
quantitative evaluation of the collateralization by MCE, we
therefore suggest to assess collateral derived relative to
normal myocardial perfusion on the basis of MBF measure-
ments during and after angioplasty. MBF measurements by
MCE have recently been introduced and validated against
PET and intracoronary Doppler in healthy volunteers and
patients with CAD.11 Moreover, as single photon emission
computed tomography10 cannot provide MBF and PET is
not applicable because of long acquisition times requiring
coronary occlusion .5 min, MBF measurements by MCE
have to be recognized as the gold standard to quantify the
collateral-derived myocardial blood supply.
Absolute parameters describing the collateral
circulation
Presence or absence of angina pectoris and ECG ST-segment
changes during balloon occlusion are related to the extent
of collateralization.7,18 However, the diagnostic value of
angina pectoris is rather qualitative and the ECG’s sensi-
tivity to detect alterations in collateralization has not yet
been deﬁned.
At present, quantitative approaches to the human coron-
ary collateralization rely on parameters such as X-ray con-
trast media clearance, radionuclide activity, and most
notably, coronary pressure and ﬂow velocity.1
It has been shown that absolute distal occlusive collateral-
ﬂow velocity as determined by intracoronary Doppler
moderately correlated with coronary wedge pressure19 and
coronary wedge pressure relative to aortic pressure.20
Quantitative assessment of 99 mTc-sestamibi perfusion
defects during angioplasty in patients with CAD further sup-
ported the association between coronary wedge pressure
and collateral-derived myocardial blood supply.10 The
results of the present study ﬁnally establish the agreement
between coronary wedge pressure and collateral-derived
myocardial blood supply (Figure 3A).
In summary, these ﬁndings indicate that absolute coronary
wedge pressure is a valuable indicator of collateral-derived
blood supply, whereas absolute distal occlusive coronary
ﬂow velocity is less reliable. This result may be explained
by inter-individual biological variability of local coronary
artery cross-sectional areas21 and ﬂow velocities, which
ﬁnally constitute coronary blood ﬂow,22 as well as by
better reliability and superior robustness of pressure when
compared with Doppler ﬂow measurements.
Figure 5 Bland–Altman analysis of pressure and perfusion derived CFIs. (A) Measurement differences (Poccl/Pao2 CPI) are plotted against mean values of
Poccl/Pao and CPI; long and short dashed lines indicate mean+ 2SD of the measurement differences (Poccl/Pao2 CPI). (B) Measurement differences
(CFIp2 CPI) are plotted against mean values of CFIp and CPI; long and short dashed lines indicate mean+ 2SD of measurement differences (CFIp2 CPI).
Figure 6 Measurement difference between pressure- and perfusion-derived
CFIs (CFIp2 CPI) vs. LVEDP.
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Relative parameters describing the collateral
circulation
Human studies on myocardial perfusion reported consider-
able heterogeneity of normal MBF data.11,23 Thus, indices
describing collateral relative to normal myocardial blood
supply are expected to be more suitable for determining
the relevance of collateral vessels. Consistently, the accu-
racy of intracoronary Doppler measurements has been
improved by normalizing coronary ﬂow velocity taken at
the same location after the removal of the stenosis and
following cessation of reactive hyperaemia.7,19
By normalizing coronary wedge pressure with aortic
pressure, Matsuo et al.10 demonstrated improved agree-
ment between pressure-derived collateral-ﬂow data and
radionuclide uptake defects during angioplasty. In our
patients, relative and absolute pressure data correlated
better with relative than with absolute collateral perfusion
(Figures 3 and 4). In other words, the scatter between
pressure- and perfusion-derived collateral data mainly
emerges from inter-individual variations of normal per-
fusion, whereas aortic and CVP vary within smaller limits.
Thus, normalization with MBF may partly explain the
improved consistency of our data when compared with the
results from Matsuo et al.10 Besides, our method features
two methodological advantages. First, the biophysical
concept of pressure-derived collateral-ﬂow measurements
is based on considerations of myocardial perfusion.
Secondly, perfusion imaging by MCE was completed during
vessel occlusion and was not impaired by delayed scanning
procedures due to the required transfer from cardiac cathe-
terization laboratory to nuclear imaging facility.
Likely unexpected for some researchers in the ﬁeld,20,24
this cross-sectional study supports the consideration of
CVP in order to increase the accuracy of pressure-derived
collateral-ﬂow data. Backpressure compensation is even
more important in the case of follow-up studies, e.g. trials
on therapeutic arteriogenesis, where it is desired to uncou-
ple collateral-ﬂow data from changing haemodynamic
parameters. We therefore recommend in agreement with
the theory6 to include CVP as well as aortic pressure for
the quantitative assessment of the collateralization by
invasive pressure measurements.
For the pressure–ﬂow relationships [Eqs. (2) and (3)] of
the angioplasty model, we assumed that coronary blood
vessels are rigid tubes, i.e. wall stress has no inﬂuence on
the coronary circulation. However, coronary vessels are
elastic and external pressures affect their haemodynamic
properties. LVEDP is recognized as a useful substitute for
wall stress, and it has been shown that collateral ﬂow was
overestimated by pressure when compared with Doppler
ﬂow measurements in the case of high LVEDP.25
Correspondingly, we found that CFIp overestimated CPI for
LVEDP .16 mmHg. This phenomenon is called coronary
waterfall: the volume ﬂowrate in a waterfall depends on
the conditions at the top of the fall and is independent of
the height of the drop.26
Non-invasive assessment of the collateral
circulation
MCE has been proposed to become the optimal tool in the
area of therapeutic angiogenesis.14 Using the quantitative
approach as presented in this study, MCE can now be
recognized as the reference method for the non-invasive
quantiﬁcation of coronary ﬂow. However, we have to stress
that invasive access is still required either to selectively
delineate collateral pathways by brief artiﬁcial vessel occlu-
sion or to conﬁrm total coronary occlusion.1 Future develop-
ments such as targeted microspheres27 or highly selective
UCA destruction will show whether a pure non-invasive
approach to the collateral function will be feasible by
MCE. For the present, MCE in conjunction with our quantiﬁ-
cation algorithm is ready for clinical studies on coronary col-
laterals in patients with documented total coronary
occlusion.
Limitations
We investigated 37 coronary arteries with their territories in
30 patients and independence of the data, a prerequisite for
the statistical analysis, may be challenged. From the techni-
cal viewpoint, the use of coronary arteries as the basic unit
for the statistical analyses is reasonable. Furthermore, the
analysis considering only the ﬁrst vessel/territory per
patient (data not shown) revealed only marginal changes
in haemodynamic statistics and did not change the signiﬁ-
cance of any result.
As a tomographic technique, the following deﬁciencies
that may inﬂuence the results are inherent in MCE: although
we took every precaution to locate the same myocardial ter-
ritory during and after angioplasty, we cannot quantify the
measurement error related to the investigation of unequal
tomographic planes. Furthermore, MCE cannot assess
collateral-related processes beyond the UCA detection
volume of the transducer.
In some patients, collateral-derived MBF was below the
range covered by the human validation study.11 However,
there are no theoretical restrictions regarding the analysis
of slow reﬁll curves.
Finally, we cannot comprehensively clarify the slight
underestimation of CPI by CFIp. It may be caused by chan-
ging haemodynamic conditions between the simultaneous
assessment of MBFc and CFIp during angioplasty and the per-
fusion follow-up after angioplasty or by MBFn reduction due
to peri-procedural embolization into the microcirculation.
Conclusion
During angioplasty, measurements of collateral-derived
MBF by contrast echocardiography are feasible and proved
the concept of coronary pressure-derived collateral-ﬂow
assessment in humans. MBF measurements by contrast echo-
cardiography represent an important step towards the non-
invasive quantiﬁcation of collateral function and are ready
to be used for clinical studies in models with documented
total vessel occlusion.
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